-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Epirubicin is a chemotherapy drug that is used to treat various types of cancer, including breast, ovarian, and liver cancer.
It is a synthetic derivative of the natural product, daunorubicin, which is obtained from the bacterium Streptomyces peucetius.
Epirubicin is a crucial anti-cancer medication and is widely used in cancer treatment.
In this article, we will discuss the synthetic routes of epirubicin.
The synthesis of epirubicin involves several steps, which can be broadly classified into two methods: the total synthesis and the semi-synthesis of the drug.
The total synthesis of epirubicin involves the synthesis of all the constituent atoms of the drug from simpler starting materials, while the semi-synthesis of epirubicin involves the synthesis of one or more parts of the drug from simpler starting materials.
- Total Synthesis of Epirubicin
The total synthesis of epirubicin involves the synthesis of all the constituent atoms of the drug from simpler starting materials.
One of the most commonly used methods for the total synthesis of epirubicin is through the use of the "norbornyl anion" intermediate.
The synthesis of epirubicin through the norbornyl anion intermediate involves the following steps:
Step 1: Synthesis of N-Bromo-2-(tert-butyldimethylsilyl)acetamide
N-Bromo-2-(tert-butyldimethylsilyl)acetamide is synthesized by reacting N-bromoacetamide with tert-butyldimethylsilyl chloride in the presence of a base such as sodium hydride.
Step 2: Reductive Amination of N-Bromo-2-(tert-butyldimethylsilyl)acetamide
N-Bromo-2-(tert-butyldimethylsilyl)acetamide is reduced to N-Bromo-2-(tert-butyldimethylsilyl)amine by heating with lithium aluminum hydride.
Step 3: Formation of the Norbornyl Anion
N-Bromo-2-(tert-butyldimethylsilyl)amine is treated with potassium hydroxide and diethyl oxalate to form the norbornyl anion.
Step 4: Synthesis of Epirubicin
The norbornyl anion is treated with various reagents such as chloroformates, sulfonates, and phosphoramidites to form the final structure of epirubicin.
- Semi-Synthesis of Epirubicin
The semi-synthesis of epirubicin involves the synthesis of one or more parts of the drug from simpler starting materials.
One of the most commonly used methods for the semi-synthesis of epirubicin is through the use of the "claisen condensation" intermediate.
The synthesis of epirubicin through the claisen condensation intermediate involves the following steps:
Step 1: Synthesis of 1-[(2-tert-butoxycarbonyl-5-methoxy-3-pentenyl)oxy]-3-nitrobenzene
1-[(2-tert-butoxycarbonyl-5-methoxy-3-pentenyl)oxy]-3-nitrobenzene is synthesized by reacting 3-nitrobenzene with 2-tert-butoxycarbonyl-5-methoxy-3-pentenal in the presence of a base such as sodium hydroxide.
Step 2: Claisen Condensation of 1-[(2-tert-butoxycarbonyl-5-methoxy-3-pentenyl)oxy]-3-nitrobenzene
1-[(2-tert-butoxycarbonyl-5